Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Patient Monitoring

See what CB Insights has to offer

Founded Year



Reverse Merger | Acquired

Total Raised


About Sontra Medical

Developer of ultrasound technology for drug delivery, fluid withdrawal, and monitoring of glucose levels for diabetics. The company develops non-invasive diagnostic and transdermal drug delivery products which utilize low frequency ultrasound to increase skin permeability. The company is performing research and development on the SonoPrep Skin Permeation System. The system is being designed to provide a convenient and painless method of enhancing transport of molecules through human skin. After a brief application of ultrasound to skin, the skin would be permeable for an extended period of time (12 to 15 hours).

Sontra Medical Headquarter Location

58 Charles Street

Cambridge, Massachusetts, 02141-2128,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Sontra Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sontra Medical is included in 1 Expert Collection, including Diabetes.



1,750 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.